|
Age, y, median (IQR)
|
|
29.5 (23 to 42) |
31 (22 to 48) |
|
Males,
n
(%)
|
|
92 (80.7) |
96 (79.3) |
|
Systolic BP, mmHg, mean (SD)
|
|
116 (19.8) |
118 (22.7) |
|
Diastolic BP, mmHg, mean (SD)
|
|
76 (13.4) |
76 (17.2) |
|
Pulse mean, bpm, mean (SD)
|
|
101 (22) |
97 (21) |
|
Time since ingestion, h, median (IQR)
|
|
4.4 (2.9 to 7.4); n = 112 |
4.3 (2.9 to 7.8); n = 116 |
|
Time since ingestion using categorical variable derived from times provided,
n
(%)
|
<4 h |
53 (46.5) |
51 (42.2) |
|
4–12 h |
41 (36.0) |
45 (37.2) |
|
>12 h |
18 (15.8) |
20 (16.5) |
|
Unknown |
2 (1.8) |
5 (4.1) |
|
Charcoal allocation for those in RCT,
n
(%)
|
Multiple dose activated charcoal |
8 (7.0) |
13 (10.7) |
|
Single dose activated charcoal |
11 (9.7) |
14 (11.6) |
|
No activated charcoal |
10 (8.8) |
13 (10.7) |
|
Not in RCT |
85 (74.6) |
81 (66.9) |
|
Charcoal treatment,
n
(%)
|
Multiple dose activated charcoal |
8 (7.0) |
13 (10.7) |
|
Single dose activated charcoal |
31 (27.2) |
42 (34.7) |
|
No activated charcoal |
75 (65.8) |
66 (54.6) |
|
GCS score, median (IQR)
|
|
15 (12 to 15) |
14 (10 to 15) |
|
GCS score on admission,
n
(%)
|
GCS 14 or 15 |
79 (69.3) |
73 (60.3) |
|
GCS<14 |
35 (30.7) |
48 (39.7) |
|
GCS 11–13 |
15 (13.2) |
16 (13.2) |
|
GCS 7–10 |
5 (4.4) |
6 (5.0) |
|
GCS 3–6 |
15 (13.2) |
26 (21.5) |
|
Intubated at baseline,
n
(%)
|
|
16 (14.0) |
24 (19.8) |
